Revised SPC: Maxidex (dexamethasone)
SPC updated following MHRA recommendation to add warnings that because of the possibility of reduced glucose tolerance/diabetes mellitus with topical ophthalmic corticosteroids, caution is recommended when administering to patients with a personal or family history of diabetes.
Source:
electronic Medicines compendium